- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
212 |
6 Congenital Ureteral Anomalies |
|
|
commonly used, the extravesical approach (detrusorrhaphy) preserves the integrity of the bladder lumen and does not require a ureteral anastomosis. Extravesical reimplantation has been shown to decrease postoperative hematuria, minimize bladder spasms, reduce the need for urethral catheter, and shorten hospital stay. Of note, transient cases of urinary retention have been reported with bilateral extravesical ureteral reimplant. Although open ureteral reimplantation remains the gold standard, minimally invasive techniques (robotic assisted ureteral reimplantation) have demonstrated comparable success rates.
•Complications of ureteral reimplantation are uncommon.
•The most common technical complications are ureteral obstruction, persistent reflux, and diverticula formation.
•Ureteral reimplantation for mega ureter repair is a very safe, reproducible, and successful procedure.
•The major complications are the development of ureteral obstruction (2–5 %) or VUR (approximately 10 %).
•Ureteral obstruction is most likely the result of ureteral ischemia and subsequent fibrosis of an excisionally tapered segment.
•Initial management of this complication is percutaneous or endoscopic dilatation and stenting of the stricture, but many such instances ultimately require open surgical revision.
•If postoperative VUR is encountered, a reasonable treatment option is observation and antibiotic prophylaxis because many reflux cases resolve spontaneously.
•In addition, VUR is more likely to recur following reimplantation in cases in which bladder pressures are elevated (e.g. patients with untreated neuropathic bladders or voiding dysfunction).
•Treatment of bladder/bowel dysfunction is indicated, preferably prior to surgical intervention of VUR. Careful assessment of voiding symptoms and a low threshold for urodynamic studies are crucial in the evaluation of patients with recurrent VUR.
•Cases of high-grade VUR are less likely to spontaneously resolve and more likely to put the kidney at risk of scarring due to pyelonephritis.
•Prevention of infection is essential to minimize the risk of renal damage; therefore, continuous antibiotic prophylaxis is usually used in children with high-grade VUR while awaiting spontaneous resolution.
•Robotic-assisted ureteral reimplantation has gained popularity and will continue to evolve with time, although open ureteral reimplantation currently remains the criterion standard for surgical management of VUR.
•Antibiotic prophylaxis for all children with VUR remains controversial, although it is recommended in children younger than 1 year with a history of febrile UTI or grade III reflux or higher.
•Bowel and bladder dysfunction are often associated with VUR and increase the risk of pyelonephritis, so should be evaluated and treated aggressively in children with VUR.
6.8Mega Ureter
•The term mega ureter refers to an enlarged ureter.
•A mega ureter is a wide ureter, greater than 7 mm in diameter (Fig. 6.40).
•Light microscopy of mega ureters demonstrates a predominance of circular smooth muscle; muscle fiber hypoplasia and atrophy, with collagen deposits separating the muscle cells; and mural fibrosis with scant muscle fibers.
•Electron microscopy of mega ureters demonstrates increased collagen deposition within the adynamic segment.
•Megaureters may be classified into the following four categories:
–Obstructed
–Refluxing
–Obstructed and refluxing
–Nonobstructed/nonrefluxing
•Each of these categories is further divided into:
–Primary
–Secondary
6.8 Mega Ureter |
213 |
|
|
Fig. 6.40 Intravenous urography showing a right mega ureter secondary to uretero-vesical junction obstruction
Classification of Mega Ureter
•Primary
•Secondary
Mega ureters are also classified into:
•Obstructive
•Reflexing
•Obstructed and refluxing
•Nonobstructed/Nonrefluxing
•This is based on their etiology, either intrinsic or extrinsic.
•Bilateral involvement is present in about 20% of patients with primary obstructed mega ureters.
•Primary obstructed mega ureter has a male-to- female ratio of nearly 4:1.
•The left side is more often affected than the right.
•Primary obstructed mega ureter:
–This is most commonly caused by an adynamic juxtavesical segment of the ureter
that fails to effectively propagate urine flow (Figs. 5.41 and 5.42).
•Secondary obstructed mega ureter:
–This occurs usually when ureteral dilatation is the result of a functional ureteral obstruction associated with elevated bladder pressures secondary to PUV or a neurogenic bladder that impedes ureteral emptying.
•Primary refluxing mega ureter:
–This is associated with severe VUR that alters ureteral efficiency by ureteral distention.
–The megaureter-megacystis syndrome is an extreme form of the primary refluxing mega ureters in which massive reflux prevents effective bladder emptying because urine is passed back and forth between the ureters and bladder.
•Secondary refluxing mega ureter:
–This occurs secondary to PUV or neurogenic bladder when elevated bladder pressures cause decompensation of the uretrovesical junction.
•Primary nonrefluxing/nonobstructed mega ureter:
–This is diagnosed when no evidence of obstruction or reflux can be demonstrated.
•Secondary nonrefluxing/nonobstructed mega ureter:
–This occurs secondary to diabetes insipidus, in which high urinary flow rates may overwhelm the maximum transport capacity of the ureter by peristalsis or as the result of ureteral atony accompanying a gram-negative UTI.
•Primary refluxing obstructed mega ureter:
–This occurs in the presence of an incompetent VUJ that allows reflux through an adynamic distal segment.
•Indications for surgical interventions:
–Increasing hydroureteronephrosis
–Decrease in renal function of involved kidney
–Development of UTI or recurrent pain
•Increasing experience shows that a considerable number of children with mega ureters without reflux or obstruction may demonstrate improved renal function on radiography, without surgical intervention.
214 |
6 Congenital Ureteral Anomalies |
|
|
Figs. 6.41 and 6.42 Intravenous urography showing megaureter. Note the small caliber of the distal ureter
•Nonoperative treatment mandates close followup care in patients with nonobstructed/nonrefluxing mega ureters.
•Nonoperative management of nonobstructed primary mega ureter includes antimicrobial suppression, treatment of voiding dysfunction, and regular imaging studies to assess renal growth, renal scarring, and possible resolution of pathology.
•Mega ureter secondary to severe VUR or obstruction is usually managed with ureteral reimplantation (Figs. 6.43, 6.44, 6.45, and 6.46).
•Reimplantation techniques are similar to those used for correcting primary VUR.
•The mega ureter can be mobilized via an intravesical, extravesical, or combined approach.
•Most mega ureters will require tapering.
•The ureteral caliber can be reduced by excising the distal redundant ureter (Hendren technique) or plication (Kalicinski technique, Starr technique) to achieve a satisfactory antireflux mechanism.
•Occasionally, the function of the kidney drained by a mega ureter is severely impaired, and nephroureterectomy may be necessary.
•There have been reports of obstructive mega ureters treated successfully by endoscopic dilation.
•Complications of ureteral reimplantation are uncommon.
•The most common technical complications are ureteral obstruction, persistent reflux, and diverticula formation.
•Ureteral reimplantation for mega ureter repair is a very safe, reproducible, and successful procedure.
•The major complications are:
–The development of ureteral obstruction (2–5 %)
–VUR (approximately 10 %).
•Ureteral obstruction is most likely the result of ureteral ischemia and subsequent fibrosis of an excisionally tapered segment.
•With respect to primary mega ureters, as in the case of VUR, spontaneous resolution is common.
•In the case of the obstructed primary mega ureter, spontaneous resolution is less likely to occur; however, a study reported a 70 % spontaneous regression.
Further Reading |
215 |
|
|
Figs. 6.43 and 6.44 Clinical intraoperative photographs showing megaureters secondary to a stenosed adynamic lower ureteric segment. Note the diameter of the stenosed
Figs. 6.45 and 6.46 Clinical intraoperative photographs showing megaureters secondary to a stenosed adynamic lower ureteric segment. Note the diameter of the stenosed
Further Reading
1. Adiego B, Martinez-Ten P, Perez-Pedregosa J, Illescas T, Barron E, Wong AE, et al. Antenatally diagnosed renal duplex anomalies: sonographic features and long-term postnatal outcome. J Ultrasound Med. 2011;30(6):809–15.
2. Adorisio O, Elia A, Landi L, Taverna M, Malvasio V, Danti AD. Effectiveness of primary endoscopic incision in treatment of ectopic ureterocele associated with duplex system. Urology. 2011;77(1):191–4.
3. Avni FE, Nicaise N, Hall M, et al. The role of MR imaging for the assessment of complicated duplex kidneys in children: preliminary report. Pediatr Radiol. 2001;31(4):215–23.
segment of the lower ureter. Note also the dilated ureter proximal to the stenotic segment
segment of the lower ureter. Note also the dilated ureter proximal to the stenotic segment
4. Bansal D, Cost NG, Bean CM, Noh PH. Pediatric laparo-endoscopic single site partial nephrectomy: feasibility in infants and small children for upper urinary tract duplication anomalies. J Pediatr Urol. 2014;10(5):859–63.
5.Bayne AP, Roth DR. Dextranomer/hyaluronic injection for the management of vesicoureteric reflux in complete ureteral duplication: should age and gender
be factors in decision making? J Endourol. 2010; 24(6):1013–6.
6. Blyth B, Passerini-Glazel G, Camuffo C, et al. Endoscopic incision of ureteroceles: intravesical versus ectopic. J Urol. 1993;149(3):556–9; discussion 560.
7. Bruno D, Delvecchio FC, Preminger GM. Successful management of lower-pole moiety ureteropelvic
216 |
6 Congenital Ureteral Anomalies |
|
|
junction obstruction in a partially duplicated collecting system using minimally invasive retrograde endoscopic techniques. J Endourol. 2000;14(9):727–30.
8. Byun E, Merguerian PA. A meta-analysis of surgical practice patterns in the endoscopic management of ureteroceles. J Urol. 2006;176(4 Pt 2):1871–7; discussion 1877.
9. Chertin B, Mohanan N, Farkas A, et al. Endoscopic treatment of vesicoureteral reflux associated with ureterocele. J Urol. 2007;178(4 Pt 2):1594–7.
10.Chowdhary SK, Lander A, Parashar K, Corkery
JJ.Single-system ectopic ureter: a 15-year review. Pediatr Surg Int. 2001;17:638.
11.Di Renzo D, Ellsworth PI, Caldamone AA, Chiesa PL. Transurethral puncture for ureterocele-which factors dictate outcomes? J Urol. 2010;184(4 Suppl):1620–4.
12.Doery AJ, Ang E, Ditchfield MR. Duplex kidney: not just a drooping lily. J Med Imaging Radiat Oncol. 2015;59(2):149–53.
13.Figueroa VH, Chavhan GB, Oudjhane K, Farhat
W.Utility of MR urography in children suspected of having ectopic ureter. Pediatr Radiol. 2014;44:956.
14. Grimsby GM, Merchant Z, Jacobs MA, Gargollo PC. Laparoscopic-assisted ureteroureterostomy for duplication anomalies in children. J Endourol. 2014;28(10): 1173–7.
15. Hanson GR, Gatti JM, Gittes KG. Diagnosis of ectopic ureter as a cause of urinary incontinence. J Pediatr Urol. 2007;3(1):53–7.
16. Husmann D, Strand B, Ewalt D, et al. Management of ectopic ureterocele associated with renal duplication: a comparison of partial nephrectomy and endoscopic decompression. J Urol. 1999;162:1406–9.
17.Kwatra N, Shalaby-Rana E, Majd M. Scintigraphic features of duplex kidneys on DMSA renal cortical
scans. Pediatr Radiol. 2013;43(9):1204–12.
18. Leavitt DA, Rambachan A, Haberman K, DeMarco R, Shukla AR. Robot-assisted laparoscopic ipsilateral ureteroureterostomy for ectopic ureters in children: description of technique. J Endourol. 2012;26(10): 1279–83.
19. Lee NG, Corbett ST, Cobb K, Bailey GC, Burns AS, Peters CA. Bi-institutional comparison of robotassisted laparoscopic versus open ureteroureterostomy in the pediatric population. J Endourol. 2015;29: 1237–41.
20.Merguerian PA, Taenzer A, Knoerlein K, McQuiston L, Herz D. Variation in management of duplex system intravesical ureteroceles: a survey of pediatric urologists. J Urol. 2010;184(4 Suppl):1625–30.
21. Nerli RB, Vernekar R, Guntaka AK, Patil SM, Jali SM, Hiremath MB. Laparoscopic hemi/partial nephrectomy in children with ureteral duplication anomalies. Pediatr Surg Int. 2011;27(7):769–74.
22. Pohl HG. Recent advances in the management of ureteroceles in infants and children: why less may be more. Curr Opin Urol. 2011;21(4):322–7.
23. Roy Choudhury S, Chadha R, Bagga D, et al. Spectrum of ectopic ureters in children. Pediatr Surg Int. 2008;24:819.
24. Rubenwolf P, Ziesel C, Beetz R, Kamal MM, Thüroff JW, Stein R. Presentation, management and long-term outcome of ureteropelvic junction obstruction in duplex kidneys. J Urol. 2015;194(2): 427–32.
25.Sakellaris G, Kumara S, Cervellione RM, Dickson AP, Gough D, Hennayake S. Outcome study of upper pole heminephroureterectomy in children. Int Urol Nephrol. 2011;43(2):279–82.
26. Stec AA, Baradaran N, Gearhart JP. Congenital renal anomalies in patients with classic bladder exstrophy. Urology. 2012;79(1):207–9.
27.Stunell H, Barrett S, Campbell N, Colhoun E, Torreggiani WC. Prolapsed bilateral ureteroceles leading to intermittent outflow obstruction. JBRBTR. 2010;93(6):312–3.
28.Timberlake MD, Corbett ST. Minimally invasive techniques for management of the ureterocele and ectopic ureter: upper tract versus lower tract approach. Urol Clin North Am. 2015;42(1):61–76.